阻塞性睡眠呼吸暂停综合征患者抗幽门螺杆菌治疗价值的临床研究
Chinese Journal for Clinicians（2013）
Abstract
目的了解抗幽门螺杆菌(Hp)治疗对阻塞性睡眠呼吸暂停综合征(OSAS)患者的价值。方法对50例Hp阳性的OSAS患者进行抗Hp治疗,治疗前及治疗后1个月进行多导睡眠图(PSG)监测、尿素[13C]呼气试验及血清白介素6(IL-6)检测,并进行Epworth嗜睡量表(ESS)评分,观察相关症状及指标改善的情况。结果 50例Hp阳性OSAS患者经过抗Hp治疗后白天嗜睡等情况明显改善,ESS评分下降,与治疗前比较差异有显著性(P<0.01);AHI明显下降,但尚未达基线水平;血清IL-6水平亦明显下降,与治疗前比较差异有显著性(P<0.01)。结论抗Hp治疗可明显改善OSAS患者相关症状及指标。
MoreTranslated text
Key words
Obstructive sleep apnea syndrome,Serum interleukin 6,Polysomnogram,Helicobacter pylori eradication
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined